BH3120
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BH3120, covering 2026-03-11 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors [Phase 1]